69097-431-15 |
69097-431 |
HUMAN PRESCRIPTION DRUG |
Darifenacin |
Darifenacin Hydrobromide |
TABLET, EXTENDED RELEASE |
ORAL |
20160901 |
N/A |
ANDA |
ANDA207664 |
Cipla USA Inc. |
DARIFENACIN HYDROBROMIDE |
7.5 mg/1 |
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-15) |
69097-432-02 |
69097-432 |
HUMAN PRESCRIPTION DRUG |
Darifenacin |
Darifenacin Hydrobromide |
TABLET, EXTENDED RELEASE |
ORAL |
20160901 |
N/A |
ANDA |
ANDA207664 |
Cipla USA Inc. |
DARIFENACIN HYDROBROMIDE |
15 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-02) |
69097-432-05 |
69097-432 |
HUMAN PRESCRIPTION DRUG |
Darifenacin |
Darifenacin Hydrobromide |
TABLET, EXTENDED RELEASE |
ORAL |
20160901 |
N/A |
ANDA |
ANDA207664 |
Cipla USA Inc. |
DARIFENACIN HYDROBROMIDE |
15 mg/1 |
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-05) |
69097-432-15 |
69097-432 |
HUMAN PRESCRIPTION DRUG |
Darifenacin |
Darifenacin Hydrobromide |
TABLET, EXTENDED RELEASE |
ORAL |
20160901 |
N/A |
ANDA |
ANDA207664 |
Cipla USA Inc. |
DARIFENACIN HYDROBROMIDE |
15 mg/1 |
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-432-15) |
69097-431-05 |
69097-431 |
HUMAN PRESCRIPTION DRUG |
Darifenacin |
Darifenacin Hydrobromide |
TABLET, EXTENDED RELEASE |
ORAL |
20160901 |
N/A |
ANDA |
ANDA207664 |
Cipla USA Inc. |
DARIFENACIN HYDROBROMIDE |
7.5 mg/1 |
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-05) |
69097-431-02 |
69097-431 |
HUMAN PRESCRIPTION DRUG |
Darifenacin |
Darifenacin Hydrobromide |
TABLET, EXTENDED RELEASE |
ORAL |
20160901 |
N/A |
ANDA |
ANDA207664 |
Cipla USA Inc. |
DARIFENACIN HYDROBROMIDE |
7.5 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-02) |